![]() |
Avastin(R) (bevacizumab) Now Approved For Use In Combination With Docetaxel For The F
More patients with metastatic breast cancer could benefit from Avastin (bevacizumab) as a result of a broader label announced by the European Commission that allows bevacizumab to be combined with either docetaxel or paclitaxel chemotherapy1.
More... |
| All times are GMT -7. The time now is 11:43 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021